A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
NCT02682238
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperhidrosis
Interventions
DRUG:
BBI-4000, 15%
OTHER:
Vehicle gel
Sponsor
Botanix Pharmaceuticals